Sponsor or institution
Clinical trials and research at Beijing Gene Key Life Technology Co., Ltd
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Beijing Gene Key Life Technology Co., Ltd that are recruiting, in China. By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
GKL-006 injections with nab-paclitaxel and gemcitabine for advanced pancreatic cancer
This study tests GKL-006 given with standard chemotherapy to see if it helps patients with unresectable or metastatic pancreatic ductal adenocarcinoma.
-
GKL-006 plus TACE vs TACE alone for unresectable liver cancer
GKL-006 injections given with TACE are being tested to see if they help people with unresectable hepatocellular carcinoma more than TACE alone.
Quick answers
How many clinical trials run by Beijing Gene Key Life Technology Co., Ltd are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.